Siena Salvatore

Plasma HER2 (ERBB2) copy number predicts response to HER2-targeted therapy in metastatic colorectal cancer / G. Siravegna, A. Sartore-Bianchi, R.J. Nagy, K. Raghav, J.I. Odegaard, R.B. Lanman, L. Trusolino, S. Marsoni, S. Siena, A. Bardelli. - In: CLINICAL CANCER RESEARCH. - ISSN 1078-0432. - 25:10(2019 May), pp. 3046-3053.

Combined low densities of FoxP3+ and CD3+ tumor-infiltrating lymphocytes identify stage II colorectal cancer at high risk of progression / T. Cavalleri, P. Bianchi, G. Basso, G. Celesti, F. Grizzi, P. Bossi, L. Greco, C. Pitrone, E. Valtorta, G. Mauri, M. Truini, F.G. Dall'Olio, G. Brandi, A. Sartore-Bianchi, L. Ricciardiello, V. Torri, L. Rimassa, S. Siena, A. Mantovani, A. Malesci, L. Laghi. - In: CANCER IMMUNOLOGY RESEARCH. - ISSN 2326-6066. - 7:5(2019 May), pp. 751-758.

A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology / G. Corti, A. Bartolini, G. Crisafulli, L. Novara, G. Rospo, M. Montone, C. Negrino, B. Mussolin, M. Buscarino, C. Isella, L. Barault, G. Siravegna, S. Siena, S. Marsoni, F. Di Nicolantonio, E. Medico, A. Bardelli. - In: CLINICAL COLORECTAL CANCER. - ISSN 1533-0028. - (2019 Mar 07). [Epub ahead of print]

Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies / G. Mauri, E.G. Pizzutilo, A. Amatu, K. Bencardino, L. Palmeri, E.F. Bonazzina, F. Tosi, G. Carlo Stella, G. Burrafato, F. Scaglione, S. Marsoni, G. Siravegna, A. Bardelli, S. Siena, A. Sartore-Bianchi. - In: CANCER TREATMENT REVIEWS. - ISSN 0305-7372. - 73(2019 Feb), pp. 41-53.

Early-onset colorectal cancer in young individuals / G. Mauri, A. Sartore-Bianchi, A. Russo, S. Marsoni, A. Bardelli, S. Siena. - In: MOLECULAR ONCOLOGY. - ISSN 1574-7891. - 13:2(2019), pp. 109-131.